Hashimoto M - Search Results

1

Negative-High Titer of Helicobacter pylori Antibody and Lipid Profiles.

Lu J, Van Hoang D, Hayashi Y, Hashimoto M, Kubo S, Kajio H, Mizoue T. Lu J, et al. Among authors: hashimoto m. Biomed Res Int. 2022 Aug 16;2022:9984255. doi: 10.1155/2022/9984255. eCollection 2022. Biomed Res Int. 2022. PMID: 36017395 Free PMC article.

2

Attenuated desensitization of β-adrenergic receptor by water-soluble N-nitrosamines that induce S-nitrosylation without NO release.

Makita N, Kabasawa Y, Otani Y, Firman, Sato J, Hashimoto M, Nakaya M, Nishihara H, Nangaku M, Kurose H, Ohwada T, Iiri T. Makita N, et al. Among authors: hashimoto m. Circ Res. 2013 Jan 18;112(2):327-34. doi: 10.1161/CIRCRESAHA.112.277665. Epub 2012 Dec 4. Circ Res. 2013. PMID: 23212582

3

V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlight protean agonism of V2R antagonists.

Takahashi K, Makita N, Manaka K, Hisano M, Akioka Y, Miura K, Takubo N, Iida A, Ueda N, Hashimoto M, Fujita T, Igarashi T, Sekine T, Iiri T. Takahashi K, et al. Among authors: hashimoto m. J Biol Chem. 2012 Jan 13;287(3):2099-106. doi: 10.1074/jbc.M111.268797. Epub 2011 Dec 5. J Biol Chem. 2012. PMID: 22144672 Free PMC article.

4

Human G(salpha) mutant causes pseudohypoparathyroidism type Ia/neonatal diarrhea, a potential cell-specific role of the palmitoylation cycle.

Makita N, Sato J, Rondard P, Fukamachi H, Yuasa Y, Aldred MA, Hashimoto M, Fujita T, Iiri T. Makita N, et al. Among authors: hashimoto m. Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17424-9. doi: 10.1073/pnas.0708561104. Epub 2007 Oct 25. Proc Natl Acad Sci U S A. 2007. PMID: 17962410 Free PMC article.

5

An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations.

Makita N, Sato J, Manaka K, Shoji Y, Oishi A, Hashimoto M, Fujita T, Iiri T. Makita N, et al. Among authors: hashimoto m. Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5443-8. doi: 10.1073/pnas.0701290104. Epub 2007 Mar 19. Proc Natl Acad Sci U S A. 2007. PMID: 17372216 Free PMC article.

6

C-Reactive Protein-Albumin Ratio Predicts Objective Response to Enfortumab Vedotin in Metastatic Urothelial Carcinoma.

Uchimoto T, Matsuda T, Komura K, Fukuokaya W, Adachi T, Hirasawa Y, Hashimoto T, Yoshizawa A, Saruta M, Hashimoto M, Higashio T, Tsuchida S, Nishimura K, Tsujino T, Nakamura K, Fukushima T, Nishio K, Yamamoto S, Iwatani K, Urabe F, Mori K, Yanagisawa T, Tsuduki S, Takahara K, Inamoto T, Miki J, Fujita K, Kimura T, Ohno Y, Shiroki R, Uemura H, Azuma H. Uchimoto T, et al. Among authors: hashimoto m. Target Oncol. 2024 May 28. doi: 10.1007/s11523-024-01068-7. Online ahead of print. Target Oncol. 2024. PMID: 38807017

7

Subtotal esophagectomy and concurrent reconstruction with free jejunal flap for primary esophageal cancer after pancreatoduodenectomy.

Moriwake K, Noma K, Kawasaki K, Matsumoto T, Hashimoto M, Kato T, Maeda N, Tanabe S, Shirakawa Y, Fujiwara T. Moriwake K, et al. Among authors: hashimoto m. Surg Case Rep. 2024 May 22;10(1):128. doi: 10.1186/s40792-024-01919-5. Surg Case Rep. 2024. PMID: 38775882 Free PMC article.

8

Effectiveness and safety of enzalutamide and apalutamide in the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC): a multicenter retrospective study.

Hara S, Mori K, Fukuokaya W, Tomomasa N, Oguchi T, Takahashi Y, Saito S, Katami J, Sano T, Kadena S, Hashimoto M, Yata Y, Nishi E, Suhara Y, Takamizawa S, Kurawaki S, Suzuki H, Miyajima K, Iwatani K, Urabe F, Ito K, Yanagisawa T, Tsuzuki S, Shimomura T, Kimura T. Hara S, et al. Among authors: hashimoto m. Int J Clin Oncol. 2024 May 20. doi: 10.1007/s10147-024-02548-6. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38769191

9

Rectal implantation cyst successfully diagnosed using endoscopic myotomy and endoscopic ultrasonography.

Kameoka E, Hikichi T, Hashimoto M, Nakamura J, Kato T, Yanagita T, Sakamoto W, Kobayakawa M, Hashimoto Y, Ohira H. Kameoka E, et al. Among authors: hashimoto m. Clin J Gastroenterol. 2024 May 18. doi: 10.1007/s12328-024-01968-1. Online ahead of print. Clin J Gastroenterol. 2024. PMID: 38761341

10

Discovery of DS44470011: An oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of renal anemia.

Fukuda T, Kuribayashi T, Takano R, Sasaki K, Tsuji T, Niitsu Y, Ishii K, Hashimoto M, Baba D, Ito S, Tanaka N. Fukuda T, et al. Among authors: hashimoto m. Bioorg Med Chem Lett. 2024 May 15;108:129799. doi: 10.1016/j.bmcl.2024.129799. Online ahead of print. Bioorg Med Chem Lett. 2024. PMID: 38754564

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,569 results

Search Page